Ozempic is an injectable medication that was approved by the FDA in 2017 to treat type 2 diabetes
The weight loss produced by GLP-1 RAs was initially attributed to their impact on the hypothalamic homeostatic circuits regulating satiety and appetite (Van Bloemendaal et al., 2014), but subsequent evidence from both animal and human studies showing that GLP-1 RAs reduce preference for energy-dense, palatable foods and blunt craving suggests that these medications might help reduce food intake by also modulating the hedonic aspects of eating (Blundell et al., 2017
[Laughs.] Anyway, so the side effects can be very uncomfortable
However, higher doses extend the duration of receptor occupancy and downstream signaling because more peptide molecules are available to bind receptors over the clearance window
A stall is actually practice for maintenance
Depending on findings, referral to a hepatologist or specialist metabolic clinic may be warranted